Clinical Update
Brixadi: A New Long-Acting Buprenorphine Option for Opioid Use Disorder
Crystal Obiozor, MD. Assistant Professor of Psychiatry, Yale University, New Haven, CT.
Noah Capurso, MD, MHS. Assistant Medical Director, Addiction Services Division, Connecticut Valley Hospital; Associate Clinical Professor of Psychiatry, Yale University; Editor-in-Chief, The Carlat Addiction Treatment Report.
Drs. Obiozor and Capurso have no financial relationships with companies related to this material.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
